Literature DB >> 2127548

Structural models for the cell surface lipooligosaccharides of Neisseria gonorrhoeae and Haemophilus influenzae.

N J Phillips1, C M John, L G Reinders, B W Gibson, M A Apicella, J M Griffiss.   

Abstract

A structural model is proposed for the surface glycolipids, or lipooligosaccharides (LOS), of gram-negative pathogenic bacteria that colonize human mucosae, e.g. Neisseria gonorrhoeae and Haemophilus influenzae. The development of this model has involved analysis of a series of pyocin-resistant mutants with altered LOS and other recent immunochemical and structural data. A comprehensive approach to determining the necessary structural data has been constructed that utilizes liquid secondary ion mass spectrometry, tandem mass spectrometry, methylation analysis and nuclear magnetic resonance. To prepare purified oligosaccharides for these analyses, chromatographic and chemical techniques have been developed that include high-pH anion-exchange chromatography of underivatized oligosaccharides and reverse-phase chromatography after derivatization with hydrazino alkyl benzoates. The proposed LOS model has several unique features that distinguish it from models developed for the lipopolysaccharides of enteric bacteria. This information should lead to an understanding of the unique structure/function relationship of LOS and to the development of carbohydrate-based vaccines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127548     DOI: 10.1002/bms.1200191112

Source DB:  PubMed          Journal:  Biomed Environ Mass Spectrom        ISSN: 0887-6134


  37 in total

1.  Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44.

Authors:  Y Tong; V Reinhold; B Reinhold; B Brandt; D C Stein
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  Sialic acid-mediated gene expression in Streptococcus pneumoniae and role of NanR as a transcriptional activator of the nan gene cluster.

Authors:  Muhammad Afzal; Sulman Shafeeq; Hifza Ahmed; Oscar P Kuipers
Journal:  Appl Environ Microbiol       Date:  2015-02-27       Impact factor: 4.792

3.  Sialic acid transport contributes to pneumococcal colonization.

Authors:  Carolyn Marion; Amanda M Burnaugh; Shireen A Woodiga; Samantha J King
Journal:  Infect Immun       Date:  2010-12-28       Impact factor: 3.441

Review 4.  Genetics of lipopolysaccharide biosynthesis in enteric bacteria.

Authors:  C A Schnaitman; J D Klena
Journal:  Microbiol Rev       Date:  1993-09

5.  Identification of a novel sialic acid transporter in Haemophilus ducreyi.

Authors:  Deborah M B Post; Rachna Mungur; Bradford W Gibson; Robert S Munson
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  The lipooligosaccharides of Haemophilus ducreyi are highly sialylated.

Authors:  W Melaugh; A A Campagnari; B W Gibson
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

7.  Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis.

Authors:  A A Campagnari; R Karalus; M Apicella; W Melaugh; A J Lesse; B W Gibson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  The tetrasaccharide L-alpha-D-heptose1-->2-L-alpha-D-heptose1--> 3-L-alpha-D-heptose1-->(3-deoxy-D-manno-octulosonic acid) and phosphate in lipid A define the conserved epitope in Haemophilus lipopolysaccharides recognized by a monoclonal antibody.

Authors:  S Borrelli; O Hegedus; D H Shaw; P E Jansson; A A Lindberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line.

Authors:  N Porat; M A Apicella; M S Blake
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.